Critic Disinvited to FDA Painkiller Meeting
286900
The US Food and Drug Administration says it plans to convene a panel of experts in February to discuss the safety of painkillers in the same class as the now-withdrawn drug Vioxx, but one member of the panel was asked not to come.
389972
A prominent drug-safety expert has been removed from a Food and Drug Administration advisory panel meeting on Vioxx and other arthritis drugs because of comments he made this week suggesting that the entire class of medications may be unsafe.
271805
Here&#39;s something to consider on your way to the medicine cabinet this morning: One of the nation&#39;s leading drug reviewers with the Food and Drug Administration told a congressional hearing last week that consumers are &quot;virtually defenseless&quot; against
590498
McALLEN - Local doctors and residents expressed concerns Tuesday that the Food and Drug Administrationâs warning to users of the over-thecounter pain reliever naproxen could unnecessarily scare patients and cause them to distrust other medications.
707318
Lester Crawford, the acting head of the US Food and Drug Administration on Friday agreed to meet with Republican Sen. Charles Grassley to discuss the FDA&#39;s handling of safety concerns over Merck&#39;s arthritis drug Vioxx.
83391
Group that protects whistle-blowers says the FDA tried to discredit an outspoken safety officer who was challenging the agency's drug safety policies.
430204
Dr. David J. Graham, the FDA drug safety reviewer who sounded warnings over five drugs he felt could become the next Vioxx has turned to a Whistleblower protection group for legal help.
6922
The Food and Drug Administration ignored danger signals from its own scientists about Merck and Co. Inc.&#39;s Vioxx painkiller, Sen. Charles Grassley told a hearing Thursday into the drug&#39;s withdrawal in September.
260784
Washington - An expert with the United States Food and Drug Administration (FDA) has said on Thursday he was pressured by his agency to stifle study results showing the potential dangers of the anti-inflammatory drug Vioxx.
258753
WASHINGTON -- The Food and Drug Administration is preventing an agency scientist from presenting the largest, most up-to-date study of popular painkillers like Bextra, Celebrex and Vioxx during an FDA meeting next week on heart risks posed by the drugs, a US senator charged.
597049
The chairman of a House committee angrily accused the Food and Drug Administration on Thursday of withholding documents on the effects of antidepressants on children.
140672
WASHINGTON - The Food and Drug Administration silenced one of its drug experts who raised safety concerns weeks before Merck & Co. yanked the blockbuster drug Vioxx due to increased risks for heart attack and strokes, the chairman of the Senate Finance Committee said Thursday...
89687
BOSTON (CBS.MW) - A Food and Drug Administration team plans to meet Thursday with the British regulators who abruptly shut down Chiron Corp.
542759
A US government medical reviewer who raised concerns about antidepressant use by children said on Thursday he was pressured to hide information and submit an altered document to congressional investigators.
129855
Dr. David Graham, the Food and Drug Administration scientist who publicly criticized the agency&#39;s approach to drug safety during a congressional hearing last week, said
397851
The controversy over painkillers known as Cox-2 inhibitors like Vioxx, Celebrex and Bextra and major cardiovascular events has prompted a leading heart specialist to speak out.
566909
The FDA decides to debate the company's lead drug.